Mobile Site ›
Print Friendly View

Test ID: TXBU    
11-Dehydro-Thromboxane B2, Urine

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Assessing if a patient will derive benefit from aspirin therapy

 

Determining an individual’s risk of coronary heart disease and stroke

 

Identifying the effectiveness of antiplatelet therapies

Additional Tests Lists test(s) that are always performed, at an additional charge, with the initial test(s)

Test IDReporting NameAvailable SeparatelyAlways Performed
AACTCreatinine, UNoYes

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

When 11-dehydro-thromboxane B2 testing is performed, urine creatinine will always be performed at no additional charge.

Method Name A short description of the method used to perform the test

TXBU: Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

AACT: Enzymatic Colorimetric Assay

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

11-Dehydro-Thromboxane B2, U

Aliases Lists additional common names for a test, as an aid in searching

*Anti-Platelet Therapy
*Aspirin Effect
*Aspirin Resistance
*Aspirin Therapy
*Platelet Activation
*Platelet Aggregation
*Platelet Inhibition
*Note: These key words are related to how other manufacturers use the 11-dehydro-thromboxane B2 analyte. Utilization of this test for these purposes is not the intent of this assay.